Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole

Jpn J Infect Dis. 2004 Jun;57(3):113-5.

Abstract

In this study, 34 clinical cerebrospinal fluid isolates of Cryptococcus neoformans were serotyped, and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole were analyzed. Of these 34 isolates, serotype A was found in 29 isolates and serotype B in the other five. The voriconazole geometric mean MIC was significantly lower than the amphotericin B/antibiotic medium 3 geometric mean MIC (P < 0.0001 at both 48 and 72 h), as well as the fluconazole geometric mean MIC (P < 0.0001 at both 48 and 72 h). Of the three antifungal agents, only fluconazole, with geometric mean MICs at both 48 and 72 h, showed significant difference between the serotypes A and B of C. neoformans.

MeSH terms

  • Amphotericin B / pharmacology
  • Amphotericin B / therapeutic use
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Cerebrospinal Fluid / microbiology*
  • Colony Count, Microbial
  • Cryptococcosis / drug therapy*
  • Cryptococcus neoformans / classification*
  • Cryptococcus neoformans / drug effects*
  • Cryptococcus neoformans / isolation & purification
  • Drug Resistance, Fungal
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use
  • Serotyping
  • Taiwan
  • Triazoles / pharmacology
  • Triazoles / therapeutic use
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Amphotericin B
  • Fluconazole
  • Voriconazole